Evaluating Characteristics Of Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment: Budesonide/formoterol Combination (bfc) Versus Tiotropium

被引：0
|
作者：
Williams, S. [1 ]
Trudo, F. [1 ]
Kern, D. [2 ]
Wessman, C. [1 ]
Tunceli, O. [2 ]
Zhou, S. [2 ]
Pethick, N. [1 ]
Elhefni, H. [1 ]
机构：
[1] Astra Zeneca LP, Wilmington, DE USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4378
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease
    Yasui, Hideki
    Inui, Naoki
    Furuhashi, Kazuki
    Nakamura, Yutaro
    Uto, Tomohiro
    Sato, Jun
    Yasuda, Kazumasa
    Takehara, Yasuo
    Suda, Takafumi
    Chida, Kingo
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2013, 26 (03) : 336 - 341
  • [22] Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease (vol 6, pg 2525, 2005)
    Centanni, S
    Di Marco, F
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (15) : 2779 - 2779
  • [23] USE OF HEALTH CARE SERVICES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATED WITH BUDESONIDE/FORMOTEROL VIA DRY POWDER INHALER (BUD/FM DPI) VERSUS TIOTROPIUM DPI
    Blais, L.
    Forget, A.
    Ramachandran, S.
    VALUE IN HEALTH, 2009, 12 (03) : A19 - A19
  • [24] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease Australian, Canadian and Swedish Healthcare Perspectives
    Mittmann, Nicole
    Hernandez, Paul
    Mellstrom, Carl
    Brannman, Lance
    Welte, Tobias
    PHARMACOECONOMICS, 2011, 29 (05) : 403 - 414
  • [25] Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
    Calverley, PM
    Boonsawat, W
    Cseke, Z
    Zhong, N
    Peterson, S
    Olsson, H
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) : 912 - 919
  • [26] Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease
    Donald P. Tashkin
    Nicola A. Hanania
    Joe McGinty
    Kimberly Denis-Mize
    Imtiaz Chaudry
    Advances in Therapy, 2009, 26 : 1024 - 1034
  • [27] Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease
    Tashkin, Donald P.
    Hanania, Nicola A.
    McGinty, Joe
    Denis-Mize, Kimberly
    Chaudry, Imtiaz
    ADVANCES IN THERAPY, 2009, 26 (11) : 1024 - 1034
  • [28] Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
    Naik, Shalini
    Kamal, Khalid M.
    Keys, Patricia A.
    Mattei, Thomas J.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2010, 2 : 25 - 36
  • [29] The surprising results of the inhaled combination budesonide/formoterol in patients with chronic obstructive respiratory disease
    Popescu, L. Livia
    Balan, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 114 - 114
  • [30] Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease
    Matsushima, Sayomi
    Inui, Naoki
    Yasui, Hideki
    Kono, Masato
    Nakamura, Yutaro
    Toyoshima, Mikio
    Shirai, Toshihiro
    Suda, Takafumi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 30 : 11 - 15
12345